Skip to main content
Email Print Share

All Images

News Release 05-011

Nanoscale Diagnostic Sets Sights on Alzheimer's

Experimental procedure detects possible traces of disease in cerebrospinal fluid

Back to article | Note about images

graph comparing diagnostic tools according to sensitivity and applicability to various bodily fluids

The bio-bar-code amplification technology, which is a million times more sensitive than enzyme-linked immunoassay (ELISA) tests, can detect ADDLs in cerebrospinal fluid where the biomarker is present in very low concentrations. The goal is to ultimately detect and validate the marker in blood.

Credit: Northwestern University

Download the high-resolution TIF version of the image. (113 KB)

Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.